ABSCI CORP Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
ABSCI CORP (ABSI) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $262.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2025-03-18
- 2024-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $262.00K.
- 2023-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $852.00K.
- 2022-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $1.67M.
- 2022-09-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $1.39M.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net |
|---|---|
| 2024-12-31 | $262.00K 10-K · filed 2025-03-18 |
| 2023-12-31 | $852.00K 10-K · filed 2024-03-21 |
| 2022-12-31 | $1.67M 10-K · filed 2023-03-30 |
| 2022-09-30 | $1.39M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.59M 10-Q · filed 2022-08-11 |
| 2021-12-31 | $26.00K 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |